Item 8.01. Other Events
On September 22, 2009, Protalix BioTherapeutics, Inc. (the "Company") issued a
press release reporting preclinical data on pr-antiTNF, a biosimilar version of
etanercept (Enbrel™). A copy of the press release is attached hereto as
Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits
99.1 Press release dated September 22, 2009.
Sign Up for a Free Trial to the NEW EDGAR Online Pro Detailed
SEC, Financial, Ownership and Offering Data on over
12,000
U.S. Public Companies. Actionable
and easy-to-use with searching, alerting, downloading
and more. Request
a TrialSign
Up Now
Add
PLX to Portfolio
Set Alert
Email to a
Friend